Vertex Pharmaceuticals, a biotechnology company that produces medicines that treat the underlying cause of cystic fibrosis and other rare diseases, has hired Jonathan Biller as chief legal officer.

Biller will oversee all of Vertex’s global legal and compliance functions. He joins Vertex from Agios Pharmaceuticals, where he served in several executive roles, including chief legal officer and, most recently, chief financial officer and head of corporate affairs.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]